• 1
    Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000; 106: 10031010.
  • 2
    Mandelbrot DA, Kishimoto K, Auchincloss H Jr, Sharpe AH, Sayegh MH. Rejection of mouse cardiac allografts by costimulation in trans. J Immunol 2001; 167: 11741178.
  • 3
    Kreisel D, Krupnick AS, Gelman AE et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med 2002; 8: 233239.
  • 4
    Miyawaki S, Nakamura Y, Suzuka H et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 1994; 24: 429434.
  • 5
    Shinkura R, Kitada K, Matsuda F et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet 1999; 22: 7477.
  • 6
    Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686688.
  • 7
    Lin X, Cunningham ET, Mu Y, Geleziunas R, Greene WC. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity 1999; 10: 271280.
  • 8
    Fagarasan S, Shinkura R, Kamata T et al. Alymphoplasia (aly) -type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J Exp Med 2000; 191: 14771486.
  • 9
    Yamada T, Mitani T, Yorita K et al. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol 2000; 165: 804812.
  • 10
    Karrer U, Althage A, Odermatt B, Hengartner H, Zinkernagel RM. Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect. Eur J Immunol 2000; 30: 27992807.
  • 11
    Hasegawa S, Miura T, Sasaki S, Madarame H, Nakane A. Dysregulation of interleukin-10 and interleukin-12 are involved in the reduced host resistance to Listeria monocytogenes infection in alymphoplastic aly mutant mice. FEMS Immunol Med Microbiol 2002; 32: 111117.
  • 12
    Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 2001; 193: 207218.
  • 13
    Gajewska BU, Alvarez D, Vidric M et al. Generation of experimental allergic airways inflammation in the absence of draining lymph nodes. J Clin Invest 2001; 108: 577583.
  • 14
    Lee BJ, Santee S, Von Gesjen S, Ware CF, Sarawar SR. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J Virol 2000; 74: 27862792.
  • 15
    Kumaraguru U, Davis IA, Deshpande S, Tevethia SS, Rouse BT. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol 2001; 166: 10661074.
  • 16
    Rennert PD, Hochman PS, Flavell RA et al. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J Exp Med 2001; 193: 12271238.
  • 17
    Guo Z, Wang J, Meng L et al. Cutting edge: membrane lymphotoxin regulates CD8 (+) T cell-mediated intestinal allograft rejection. J Immunol 2001; 167: 47964800.
  • 18
    Chin R, Zhou P, Alegre ML, Fu YX. Confounding factors complicate conclusions in aly model. Nat Med 2001; 7: 11651166.
  • 19
    De Togni P, Goellner J, Ruddle NH et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264: 703707.
  • 20
    Fu YX, Huang G, Matsumoto M, Molina H, Chaplin DD. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc Natl Acad Sci USA 1997; 94: 57395743.
  • 21
    Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997; 6: 491500.
  • 22
    Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9: 5970.
  • 23
    Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343350.
  • 24
    Szot GL, Zhou P, Sharpe AH et al. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation 2000; 69: 904909.
  • 25
    Szot GL, Zhou P, Rulifson I et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1: 3846.
  • 26
    Chalasani G, Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 2002; 99: 61756180.
  • 27
    Matsumoto M, Iwamasa K, Rennert PD et al. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. J Immunol 1999; 163: 15841591.
  • 28
    Wu Q, Salomon B, Chen M et al. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 2001; 193: 13271332.
  • 29
    Ettinger R, Munson SH, Chao CC, Vadeboncoeur M, Toma J, McDevitt HO. A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice. J Exp Med 2001; 193: 13331340.
  • 30
    Hasegawa S, Becker G, Nagano H, Libby P, Mitchell RN. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol 1998; 153: 6979.
  • 31
    Tamada K, Shimozaki K, Chapoval AI et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 2000; 6: 283289.
  • 32
    Tamada K, Ni J, Zhu G et al. Cutting edge: selective impairment of CD8 (+) T cell function in mice lacking the TNF superfamily member LIGHT. J Immunol 2002; 168: 48324835.
  • 33
    Ye Q, Fraser CC, Gao W et al. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med 2002; 195: 795800.
  • 34
    Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708712.